Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China · Delayed Price · Currency is CNY 4.440
+0.010 (0.23%)
Apr 28, 2026, 3:00 PM CST
SHA:600572 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 500.6 | 491.55 | 622.42 | 591.57 | 358.12 | 2,017 |
Depreciation & Amortization | 344.74 | 344.74 | 337.8 | 324.35 | 277.48 | 286.68 |
Other Amortization | 10.06 | 10.06 | 16.19 | 8.77 | 9.38 | 17.41 |
Loss (Gain) From Sale of Assets | -4.98 | -4.98 | -20.55 | -35.68 | -36.51 | -43.18 |
Asset Writedown & Restructuring Costs | 29.82 | 29.82 | 5.46 | 7.18 | 2.33 | 96.67 |
Loss (Gain) From Sale of Investments | -79.61 | -79.61 | -96.87 | 61.31 | 202.15 | -1,881 |
Provision & Write-off of Bad Debts | - | - | 1.63 | 1.07 | 0.24 | 36.57 |
Other Operating Activities | 69.63 | 8.48 | 99.27 | 155.42 | 163.86 | 269.06 |
Change in Accounts Receivable | 156.52 | 156.52 | 138 | -271.44 | 47.95 | -360.47 |
Change in Inventory | 7.22 | 7.22 | 19.2 | -244.97 | -111.02 | -158.76 |
Change in Accounts Payable | -40.85 | -40.85 | -145.41 | 358.69 | 246.19 | 341.51 |
Change in Other Net Operating Assets | 10.98 | 10.98 | 24 | 26.36 | 4.79 | 30.52 |
Operating Cash Flow | 1,013 | 942.61 | 1,013 | 898.64 | 1,155 | 891.23 |
Operating Cash Flow Growth | 1.09% | -6.91% | 12.67% | -22.23% | 29.65% | -28.68% |
Capital Expenditures | -134.19 | -147.26 | -290.63 | -209.14 | -291.75 | -581.42 |
Sale of Property, Plant & Equipment | 25.63 | 25.53 | 23.83 | 96.34 | 164.01 | 21.02 |
Cash Acquisitions | - | - | - | 8.79 | -206.31 | - |
Divestitures | - | - | - | - | -0.01 | 1,479 |
Investment in Securities | -379.4 | 21.34 | 22.74 | -207.13 | 94.24 | 168.48 |
Other Investing Activities | 37.15 | 35.85 | 32.56 | 22.09 | 28.72 | 0.31 |
Investing Cash Flow | -450.81 | -64.54 | -211.5 | -289.05 | -211.11 | 1,087 |
Long-Term Debt Issued | - | 282.03 | 750.27 | 1,755 | 1,760 | 1,912 |
Total Debt Issued | 238.43 | 282.03 | 750.27 | 1,755 | 1,760 | 1,912 |
Long-Term Debt Repaid | - | -403.99 | -1,565 | -1,716 | -2,060 | -2,791 |
Net Debt Issued (Repaid) | -107.97 | -121.96 | -815.11 | 38.44 | -300.45 | -879.27 |
Issuance of Common Stock | 58.43 | 55.52 | 48.7 | - | 1.5 | - |
Repurchase of Common Stock | - | - | -299.99 | - | - | - |
Common Dividends Paid | -382.2 | -383.64 | -523.54 | -420.13 | -490.35 | -85.01 |
Other Financing Activities | -37.67 | -43.38 | -324.96 | -337.4 | -135.41 | -61.74 |
Financing Cash Flow | -469.41 | -493.45 | -1,915 | -719.08 | -924.71 | -1,026 |
Foreign Exchange Rate Adjustments | -5.03 | -1.55 | 5.11 | 2.99 | 9.11 | 0.05 |
Net Cash Flow | 87.56 | 383.06 | -1,109 | -106.51 | 28.77 | 952.21 |
Free Cash Flow | 878.62 | 795.35 | 721.9 | 689.5 | 863.73 | 309.8 |
Free Cash Flow Growth | 17.21% | 10.17% | 4.70% | -20.17% | 178.80% | -60.75% |
Free Cash Flow Margin | 13.13% | 12.29% | 11.08% | 10.24% | 14.39% | 4.72% |
Free Cash Flow Per Share | 0.35 | 0.32 | 0.28 | 0.27 | 0.34 | 0.12 |
Cash Income Tax Paid | 646.27 | 646.27 | 518.05 | 722.62 | 562.67 | 619.14 |
Levered Free Cash Flow | 601.67 | 773.42 | 518.17 | 664.78 | 602.51 | -18.09 |
Unlevered Free Cash Flow | 601.67 | 773.42 | 531.16 | 687.53 | 633.43 | 27.67 |
Change in Working Capital | 142.55 | 142.55 | 47.18 | -215.36 | 178.43 | 91.26 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.